AVE0991 sodium salt is a potent non-peptide Mas receptor agonist of Ang-(1-7), used to study the physiological and pharmacological effects mediated by the Mas receptor. It mimics the effects of Ang-(1-7) on the endothelium, promoting nitric oxide (NO) and superoxide (O₂⁻) release, with a higher bioactive NO yield compared to Ang-(1-7). In vivo, it exhibits antidiuretic effects by reducing urinary volume and increasing urine osmolality in water-loaded mice, which is dependent on the presence of the Mas receptor. Additionally, chronic administration of AVE0991 reduces perfusion pressure and enhances cardiac contractility parameters—including systolic tension, rate of tension rise (+dT/dt), and rate of tension fall (−dT/dt)—in rats, with a slight increase in heart rate.